Selling One Cosmetic Formula Across Five Markets

The dream is one formula, one production run, five markets. The reality is that Canada, the US, the EU, the UK, and Australia each run their own rulebook, and none of them were written with your convenience in mind. But you can get closer to the dream than most makers assume, if you build the formula around the strictest common denominator from the start.

Start by mapping what each market actually asks for

Before touching your formula, get clear on the shape of each regulator's process, because the differences matter for planning, not just compliance:

• Canada: a Cosmetic Notification Form filed through the Cosmetic Notification System, a notification rather than a pre-market approval, due within 10 days of first sale, checked against the Cosmetic Ingredient Hotlist, with bilingual English/French labeling
• United States: MoCRA requires facility registration and product listing with the FDA, a named responsible person, and safety substantiation (some small businesses are exempt from registration and listing)
• European Union: notification via the CPNP portal under Regulation (EC) No 1223/2009, with an EU-established Responsible Person, a Product Information File, and a Cosmetic Product Safety Report signed by a safety assessor
• United Kingdom: notification via the OPSS Submit Cosmetic Product Notification service, its own track since Brexit
• Australia: AICIS regulates the ingredients in your formula as industrial chemicals through an Inventory and introduction categories, rather than notifying the finished product itself

The strictest common denominator approach

Rather than formulating five slightly different versions of your product, build one formula that would pass the toughest ingredient restriction across all five markets. In practice this means:

1. Cross-reference restricted and prohibited ingredient lists across each market before finalizing your formula, not after. An ingredient allowed at a certain concentration in one market but restricted more tightly in another should be formulated to the tighter limit if you want true one-formula simplicity.
2. Design for the toughest labeling regime. If your formula will be sold in Canada, plan for bilingual labeling from the start rather than retrofitting it later. Build allergen disclosure into your standard label template too, since Canada's fragrance allergen requirements (List 1 mandatory April 12, 2026, List 2 mandatory August 1, 2026) will apply regardless of what other markets currently require.
3. Avoid ingredients that require different treatment in different places. Nanomaterial UV filters, certain preservatives, and some botanical extracts can carry different requirements market to market. If an ingredient forces you to maintain two versions of your formula, it's worth asking whether a substitute exists that doesn't.

Where "one formula" still needs market-specific paperwork

Even with a genuinely identical formula, you can't avoid separate regulatory processes in each market. A harmonized formula still needs:

Market	What still has to happen separately
Canada	CNF filing, CN number, Hotlist screening, bilingual label
United States	MoCRA facility registration and product listing, responsible person named
EU	CPNP notification, EU Responsible Person appointed, PIF and CPSR prepared
UK	SCPN notification
Australia	AICIS chemical introduction status confirmed for each ingredient

The formula can be one thing. The compliance trail behind it is five separate things, and trying to shortcut that by assuming one market's paperwork covers another is where brands get into trouble.

Sequencing matters

Most makers don't launch in all five markets simultaneously, and that's fine, in fact it's usually smarter. A common sequence is home market first (wherever your production and testing infrastructure already sits), then the market with the most overlapping requirements to your home market's rules, then the rest. Each new market launch is a chance to catch a restriction or labeling requirement you didn't know about before it becomes a bigger problem across a wider footprint.

The ingredient record is the real asset

The thing that actually makes multi-market selling manageable isn't the formula itself, it's having a single clean source of truth for every ingredient: INCI name, CAS number, function, concentration, and supplier documentation. Build that once, accurately, and every market's paperwork becomes a matter of applying that same data to a different form, rather than reconstructing your ingredient list from scratch each time.

Cosmetic Comply already handles this kind of ingredient matching, screening, and filing for Canada, with the US, EU, and Australia in development, and lets you duplicate a past filing for close variants, which is exactly the workflow a one-formula, multi-market brand needs as it expands one regulator at a time.